Information Centre
NEWS
QUALITY
ACCURACY SPEED
born of feeling

Corporate News

  • 2022-12-14
    Recently, Difei Medical Technology (Nanjing) Co., Ltd. (hereinafter referred to as 'Difei Medical') announced the completion of tens of millions of RMB A+ round of financing. This round of financing was invested by Ruiyoukang Fund, a subsidiary of Jiangbei Science and Technology Investment Group. It is used for Difei medical technology research and development, product registration and clinical cooperation promotion, etc.Founded in 2018, Difei Medical was conceived and incubated by Shihe Gene, a leader in the field of tumor precision medicine in China. It is a high-tech enterprise focusing on the development and service of clinical molecular detection technology for pathogenic microorganisms.The company's headquarters is located in Jiangbei New District, a national-level new area. It has a R&D and commercial operation team of more than 100 people from top universities at home and abroad and multidisciplinary.Following prenatal screening and precise diagnosis of tumors, technological advances in high-throughput sequencing and liquid biopsy have promoted the vigorous development of the field of pathogenic microorganisms.The technology has the advantages of not relying on culture, directly acting on clinical samples, unbiased detection, and being able to detect rare and new pathogens.
  • 2022-12-14
    Recently, the Clinical Laboratory Center of the National Health and Medical Commission announced the results of the external quality evaluation of metagenomic sequencing of lower respiratory tract infections nationwide. A total of 90 enterprises and hospitals across the country participated in the evaluation, with a pass rate of 44.4%. Difei Medical successfully passed the external quality evaluation with high scores .
  • Total 3 pages  Go to Page
  • Go

Scientific Article

Industry News

  • 2023-06-08
    A few days ago, the Nanjing Science and Technology Bureau announced the 2023 Nanjing Engineering Technology Research Center Certification List.'Nanjing Infection Metagenome Engineering Technology Research Center' built by Difei Medical Technology (Nanjing) Co., Ltd. has been recognized through the procedures of district-level competent department recommendation, expert review, director's office meeting deliberation, and public announcement!
  • 2023-06-06
    The development of modern science and technology promotes medical progress. Metagenomic next-generation sequencing (mNGS) technology has gradually entered the clinic from the laboratory and into the public eye, playing a key role in the diagnosis of many patients with difficult infections .
  • 2022-06-16
    Difei Medical Technology (Nanjing) Co., Ltd. is a star enterprise under Nanjing Shihe Gene Biotechnology Co., Ltd.As a pioneer in the field of pathogenic microorganism detection in China, Difei Medical adheres to the corporate mission of 'born from the sense' and aims at 'innovating technology, transforming medical treatment' to create a more professional and clinically suitable testing product line , Escort the health of the public with advanced medical technology and services.

About Dinfectome

Telephone: + 86 - 4006362325
E-mail: marketing@dinfectome.com
Address: No.128 Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province, China
Leave a Message
Cooperation

Follow Us

Copyright© 2023 Difei Medical Technology (Nanjing) Co., Ltd. Su ICP No. 20046744-2 All rights reserved | Sitemap | Privacy Policy | Leadong support